Agios Pharmaceuticals Inc. logo

Agios Pharmaceuticals Inc. (0HB0)

Market Open
27 Jul, 15:30
LSE LSE
$
37. 49
+1.51
+4.1968%
$
- Market Cap
- P/E Ratio
- Div Yield
96 Volume
- Eps
$ 35.98
Previous Close
Add Transaction
Day Range
36.25 37.75
Year Range
22.4 45.81
Want to track 0HB0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Agios Pharmaceuticals Inc. (0HB0) Statistics

Valuation metrics

Market Cap -
Enterprise value 2.08B
Trailing P/E (ttm) -5.02
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 32.74
Price/Book (mrq) 1.93
Enterprise Value/Revenue 31.56
Enterprise Value/EBITDA -4.98

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 410
Average volume (90 days) 621

Price summary

52-Week low 22.4
52-Week high 45.81
Beta -
50-Day moving average 35.98
200-Day moving average 30.56

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -6.4%
Operating margin -7.2%

Operational effectiveness

Return on assets -0.36%
Return on equity -0.34%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.19
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 12.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 14.19%
Book value per share (mrq) 18.87

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -